Skip to search.
 FTSE 100 Up 3.08%

Gilead Sciences Inc. (GILD)

-NasdaqGS
89.18 Up 1.82(2.08%) 18:14 - Nasdaq Real Time Price
Prev Close:87.36
Open:88.36
Bid:89.73 x 100
Ask:89.74 x 700
1y Target Est:118.63
Beta:1.40682
Earnings Date:28 Apr - 2 May (Est.)
Day's Range:86.68 - 89.75
52wk Range:81.89 - 123.37
Volume:6,133,699
Avg Vol (3m):11,078,100
Market Cap:126.81b
P/E (ttm):7.49
EPS (ttm):11.91
Div & Yield:1.72 (1.96%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDUp 2.08%126.81b
GSKUp 0.95%95.64b
PFEDown 0.07%179.71b

Key Statistics

Forward P/E (1 yr):7.20
P/S (ttm):3.81
Ex-Dividend Date:14-Dec-15

Analysts

Annual EPS Est (Dec-16) :12.18
Quarterly EPS Est (Mar-16) :3.08
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.35

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical need in North America, South America, Europe, and the Asia-Pacific. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback